$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
Nvni Group Receives Non-Compliance Notice from Nasdaq
04:05pm, Thursday, 17'th Apr 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private SaaS B2B companies in Latin America, has received noti
RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
04:01pm, Thursday, 17'th Apr 2025
The Notification Letter has no immediate effect on the Company's listing on the Nasdaq Capital Market at this time, nor are the Company's business operations affected by receipt of the Notification Le
CHAGEE Rings the Opening Bell on The Nasdaq
02:15pm, Thursday, 17'th Apr 2025
Company Celebrates Transition to a Public Company; Shares Trade Under “CHA” Ticker Company Celebrates Transition to a Public Company; Shares Trade Under “CHA” Ticker
Nasdaq 100: Tech Stocks Slammed Again Today After Alphabet Antitrust Ruling and Nvidia Hit
11:16am, Thursday, 17'th Apr 2025
Nasdaq pressured by tech losses, S&P 500 vulnerable. Google faces DOJ breakup risk, while traders brace for Netflix earnings after market close today.
Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 17'th Apr 2025
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Delray Beach, FL, April 17, 2025 (GLOBE NEWSWIRE) -- The US ESG Reporting Software Market is expected to reach USD 0.71 billion in 2029 from USD 0.35 billion in 2024, at a CAGR of 15.2% during the for
Cadrenal Therapeutics to Present at Inaugural Centri Capital Conference at Nasdaq
09:40am, Thursday, 17'th Apr 2025
PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #CadrenalTherapeutics--Cadrenal Therapeutics to present at inaugural Centri Capital Conference at Nasdaq on April 22, 2025.
These Were the 2 Top-Performing Stocks in the Nasdaq-100 in March 2025
07:23am, Thursday, 17'th Apr 2025
March 2025 was a rough month for the stock market. Only 23 stocks on the tech-heavy Nasdaq-100 index posted positive returns, leaving 76 tickers in negative territory for the month.
1 Screaming Bargain Investors Can't Afford to Miss Out On During the Nasdaq Bear Market
07:00am, Thursday, 17'th Apr 2025
While many stocks have been affected by the marketwide sell-off, few stocks have had as much bad luck as The Trade Desk (TTD -1.60%). The Trade Desk has been hit by two sell-offs, the first being self
S&P500 and Nasdaq 100: UnitedHealth, Netflix Earnings Set to Test Stock Market Sentiment
06:00am, Thursday, 17'th Apr 2025
S&P500 and Nasdaq 100 could react strongly to UnitedHealth, Netflix earnings. Explore the stock market outlook and what these results mean for traders.
Faraday Future Announces That It Resolutely Opposes a Reverse Stock Split, Is Committed to Maintaining Nasdaq Listing
05:49am, Thursday, 17'th Apr 2025
LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (“FF” or the “Company”) (NASDAQ: FFAI) today announced a five-point action plan aimed at protecting stockholder value and
Nasdaq Dips 3% Amid Plunge In Nvidia, AMD: Greed Index Remains In 'Extreme Fear' Zone
03:41am, Thursday, 17'th Apr 2025
The CNN Money Fear and Greed index showed a further increase in the overall fear level, while the index remained in the “Extreme Fear” zone on Wednesday.
SKK HOLDINGS LIMITED ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION LETTER REGARDING MINIMUM PRICE DEFICIENCY
05:28pm, Wednesday, 16'th Apr 2025
SINGAPORE, April 16, 2025 (GLOBE NEWSWIRE) -- SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a civil engineering service provider that specializes in subsurface utility works in
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Wednesday, 16'th Apr 2025
CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today a
BALA CYNWYD, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (
Sign In
Buy NDAQ